Want to see ABVX full AI Analyst Report?
ETFs with Abivax SA Sponsored ADR (ABVX) Exposure
The following ETFs maintain exposure to Abivax SA Sponsored ADR (ABVX). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
20 ETFs Hold Abivax SA Sponsored ADR (ABVX)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in ABVX |
|---|---|---|---|---|---|---|
| W311 | HANetf ICAV - HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF Accum-USD- | $14.14M | 0.89% | 2.33% | $329.52K | <0.01% |
| GVIP | Goldman Sachs Hedge Industry VIP ETF | $555.93M | 0.45% | 1.68% | $8.97M | 0.12% |
| MEDI | Harbor Health Care ETF | $45.93M | 0.80% | 1.59% | $731.81K | <0.01% |
| GURU | Global X Guru Index ETF | $58.75M | 0.75% | 1.02% | $608.64K | <0.01% |
| FRTY | Alger Mid Cap 40 ETF | $146.55M | 0.60% | 0.85% | $1.25M | 0.02% |
| ORR | Militia Long/Short Equity ETF | $347.75M | 10.91% | 0.58% | $2.01M | 0.03% |
| IBB | iShares Biotechnology ETF | $11.52B | 0.44% | 0.43% | $49.14M | 0.65% |
| OM3E | iShares NASDAQ US Biotechnology UCITS ETF | $78.53M | 0.37% | 0.32% | $4.31M | 0.06% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | $120.43M | 0.19% | 0.31% | $378.92K | <0.01% |
| MSSM | Morgan Stanley Pathway Small-Mid Cap Equity ETF | $708.38M | 0.62% | 0.27% | $1.89M | 0.02% |
| TDNA | T. Rowe Price Biotech ETF | $11.32M | 0.55% | 0.24% | $27.52K | <0.01% |
| ESIM | Eventide International ETF | $29.98M | 0.59% | 0.09% | $26.06K | <0.01% |
| TNXT | T. Rowe Price Innovation Leaders ETF | $19.28M | 0.49% | 0.04% | $7,391.98 | <0.01% |
| APIE | ActivePassive International Equity ETF | $1.13B | 0.45% | 0.03% | $298.62K | <0.01% |
| ONEQ | Fidelity Nasdaq Composite Index ETF | $10.76B | 0.21% | 0.01% | $1.32M | 0.02% |
| PINK | Simplify Health Care ETF | $335.60M | 0.51% | <0.01% | $19.05K | <0.01% |
| VGK | Vanguard FTSE Europe ETF | $29.73B | 0.06% | <0.01% | $457.77K | <0.01% |
| VIU | Vanguard exNA Idx Un | $11.53B | 0.23% | <0.01% | $90.78K | <0.01% |
| VEU | Vanguard FTSE All-World ex-US Index Fund | $67.31B | 0.04% | <0.01% | $446.78K | <0.01% |
| FENI | Fidelity Enhanced International ETF | $11.69B | 0.28% | <0.01% | $4,363.94 | <0.01% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in ABVX |
|---|---|---|---|---|---|---|
| W311 | 2.33% | HANetf ICAV - HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF Accum-USD- | $14.14M | 0.89% | $329.52K | <0.01% |
| GVIP | 1.68% | Goldman Sachs Hedge Industry VIP ETF | $555.93M | 0.45% | $8.97M | 0.12% |
| MEDI | 1.59% | Harbor Health Care ETF | $45.93M | 0.80% | $731.81K | <0.01% |
| GURU | 1.02% | Global X Guru Index ETF | $58.75M | 0.75% | $608.64K | <0.01% |
| FRTY | 0.85% | Alger Mid Cap 40 ETF | $146.55M | 0.60% | $1.25M | 0.02% |
| ORR | 0.58% | Militia Long/Short Equity ETF | $347.75M | 10.91% | $2.01M | 0.03% |
| IBB | 0.43% | iShares Biotechnology ETF | $11.52B | 0.44% | $49.14M | 0.65% |
| OM3E | 0.32% | iShares NASDAQ US Biotechnology UCITS ETF | $78.53M | 0.37% | $4.31M | 0.06% |
| IBBQ | 0.31% | Invesco Nasdaq Biotechnology ETF | $120.43M | 0.19% | $378.92K | <0.01% |
| MSSM | 0.27% | Morgan Stanley Pathway Small-Mid Cap Equity ETF | $708.38M | 0.62% | $1.89M | 0.02% |
| TDNA | 0.24% | T. Rowe Price Biotech ETF | $11.32M | 0.55% | $27.52K | <0.01% |
| ESIM | 0.09% | Eventide International ETF | $29.98M | 0.59% | $26.06K | <0.01% |
| TNXT | 0.04% | T. Rowe Price Innovation Leaders ETF | $19.28M | 0.49% | $7,391.98 | <0.01% |
| APIE | 0.03% | ActivePassive International Equity ETF | $1.13B | 0.45% | $298.62K | <0.01% |
| ONEQ | 0.01% | Fidelity Nasdaq Composite Index ETF | $10.76B | 0.21% | $1.32M | 0.02% |
| PINK | <0.01% | Simplify Health Care ETF | $335.60M | 0.51% | $19.05K | <0.01% |
| VGK | <0.01% | Vanguard FTSE Europe ETF | $29.73B | 0.06% | $457.77K | <0.01% |
| VIU | <0.01% | Vanguard exNA Idx Un | $11.53B | 0.23% | $90.78K | <0.01% |
| VEU | <0.01% | Vanguard FTSE All-World ex-US Index Fund | $67.31B | 0.04% | $446.78K | <0.01% |
| FENI | <0.01% | Fidelity Enhanced International ETF | $11.69B | 0.28% | $4,363.94 | <0.01% |
Popular ETF Comparisons
ABVX ETF Exposure FAQ
What ETFs hold Abivax SA Sponsored ADR stock?
Abivax SA Sponsored ADR (ABVX) is currently held by 20 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to ABVX include iShares (IBB), Goldman Sachs (GVIP) and iShares (DE:OM3E).
Which ETF has the largest exposure to ABVX?
The ETF with the largest exposure to ABVX is iShares (IBB), with approximately $49.14M in market value exposure.
How much ABVX stock is held by ETFs?
ETFs currently hold approximately $69.63M worth of Abivax SA Sponsored ADR (ABVX) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.
